Abstract
Abnormalities in cardiac structure and function are very common among people with chronic kidney disease, in whom cardiovascular disease is the major cause of death. Dietary soy protein and fish oil reduce kidney disease progression in the Han:SPRD-Cy model of cystic renal disease. However, the effects of these dietary interventions in preventing alterations in cardiac structure and function due to kidney disease (reno-cardiac syndrome) in a cystic kidney disease model are not known. Therefore, weanling Han:SPRD-Cy diseased (Cy/+) and normal (+/+) rats were given diets containing either casein or soy protein, and either soy or fish oil in a three-way design for 8 weeks. Diseased rats had larger hearts, augmented left ventricular mass, and higher systolic and mean arterial blood pressure compared to the normal rats. Assessment of cardiac function using two-dimensional guided M-mode and pulse-wave Doppler echocardiography revealed that isovolumic relaxation time was prolonged in the diseased compared to normal rats, reflecting a diastolic heart dysfunction, and fish oil prevented this elevation. Soy protein resulted in a small improvement in systolic and mean arterial pressure but did not improve diastolic heart function, while fish oil prevented diastolic heart dysfunction in this model of cystic kidney disease.
Similar content being viewed by others
Abbreviations
- CKD:
-
Cystic kidney disease
- CO:
-
Cardiac output
- CP:
-
Casein protein
- EF:
-
Ejection fraction
- ESRD:
-
End-stage renal disease
- ET:
-
Ejection time
- FO:
-
Fish oil
- IVRT:
-
Isovolumic relaxation time
- LVH:
-
Left ventricular hypertrophy
- LVIDd:
-
Left ventricular internal dimension at diastole
- LVM:
-
Left ventricular mass
- MAP:
-
Mean arterial blood pressure
- SO:
-
Soy oil
- SP:
-
Soy protein
References
Corradi V, Gastaldon F, Virzi GM, de Cal M, Soni S, Chionh C, Cruz DN, Clementi M, Ronco C (2009) Clinical pattern of adult polycystic kidney disease in a northeastern region of Italy. Clin Nephrol 72(4):259–267
Fick GM, Johnson AM, Strain JD, Kimberling WJ, Kumar S, Manco-Johnson ML, Duley IT, Gabow PA (1993) Characteristics of very early onset autosomal dominant polycystic kidney disease. J Am Soc Nephrol 3(12):1863–1870
Niemczyk M, Niemczyk S, Paczek L (2009) Autosomal dominant polycystic kidney disease and transplantation. Ann Transplant 14(4):86–90
Wuthrich RP, Mei C (2014) Pharmacological management of polycystic kidney disease. Expert Opin Pharmacother 15(8):1085–1095
Chen D, Ma Y, Wang X, Yu S, Li L, Dai B, Mao Z, Sun L, Xu C, Rong S, Tang M, Zhao H, Liu H, Serra AL, Graf N, Liu S, Wuthrich RP, Mei C (2014) Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease. PLoS One 9(3):e92232
Virzi GM, Corradi V, Panagiotou A, Gastaldon F, Cruz DN, de Cal M, Clementi M, Ronco C (2010) ADPKD: prototype of cardiorenal syndrome type 4. Int J Nephrol 2011:490795
Bardaji A, Martinez Vea A, Gutierrez C, Ridao C, Richart C, Oliver JA (1998) Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease. Am J Kidney Dis 32(6):970-975
Lee M, Saver JL, Huang WH, Chow J, Chang KH, Ovbiagele B (2010) Impact of elevated cystatin C level on cardiovascular disease risk in predominantly high cardiovascular risk populations: a meta-analysis. Circ Cardiovasc Qual Outcomes 3(6):675-683
Shlipak MG, Fried LF, Stehman-Breen C, Siscovick D, Newman AB (2004) Chronic renal insufficiency and cardiovascular events in the elderly: findings from the cardiovascular health study. Am J Geriatr Cardiol 13(2):81–90
London GM (2002) Left ventricular alterations and end-stage renal disease. Nephrol Dial Transplant 17(Suppl 1):29–36
Grabysa R, Wankowicz Z (2013) Echocardiographic markers of left ventricular dysfunction among men with uncontrolled hypertension and stage 3 chronic kidney disease. Med Sci Monit 19:838–845
Fick GM, Johnson AM, Hammond WS, Gabow PA (1995) Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 5(12):2048–2056
Cowley BD, Gudapaty S, Kraybill AL, Barash BD, Harding MA, Calvet JP, Gattone VH (1993) Autosomal-dominant polycystic kidney disease in the rat. Kidney Int 43(3):522–534
Kaspareit-Rittinghausen J, Deerberg F, Wcislo A (1991) Hereditary polycystic kidney disease. Adult polycystic kidney disease associated with renal hypertension, renal osteodystrophy, and uremic enteritis in SPRD rats. Am J Pathol 39(3):693–696
Ibrahim NH, Gregoire M, Devassy JG, Wu Y, Yoshihara D, Yamaguchi T, Nagao S, Aukema HM (2015) Cyclooxygenase product inhibition with acetylsalicylic acid slows disease progression in the Han:SPRD-Cy rat model of polycystic kidney disease. Prostaglandins Other Lipid Mediat 116-117C:19–25
Ibrahim NH, Jia Y, Devassy JG, Yamaguchi T, Aukema HM (2013) Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat. Mol Nutr Food Res 58(4):768–781
Ogborn MR, Bankovic-Calic N, Shoesmith C, Buist R, Peeling J (1998) Soy protein modification of rat polycystic kidney disease. Am J Physiol 274(3 43-3):F541–F549
Cahill LE, Peng CY, Bankovic-Calic N, Sankaran D, Ogborn MR, Aukema HM (2007) Dietary soya protein during pregnancy and lactation in rats with hereditary kidney disease attenuates disease progression in offspring. Br J Nutr 97(1):77–84
Aukema HM, Lu J, Borthwick F, Proctor SD (2012) Dietary fish oil reduces glomerular injury and elevated renal hydroxyeicosatetraenoic acid levels in the JCR:LA-cp rat, a model of the metabolic syndrome. Br J Nutr 110(1):11–19
Anderson JW, Johnstone BM, Cook-Newell ME (1995) Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333(5):276–282
Lu J, Bankovic-Calic N, Ogborn M, Saboorian MH, Aukema HM (2003) Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats. J Nutr 133(1):180–186
Lefkowith JB, Klahr S (1996) Polyunsaturated fatty acids and renal disease. Proc Soc Exp Biol Med 213(1):13–23
Rangel-Huerta OD, Aguilera CM, Mesa MD, Gil A (2012) Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 107(Suppl 2):S159–S170
Fassett RG, Gobe GC, Peake JM, Coombes JS (2010) Omega-3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis 56(4):728–742
Himmelfarb J, Phinney S, Ikizler TA, Kane J, McMonagle E, Miller G (2007) Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients. J Ren Nutr 17(5):296–304
Virtanen JK, Mozaffarian D, Chiuve SE, Rimm EB (2008) Fish consumption and risk of major chronic disease in men. Am J Clin Nutr 88(6):1618–1625
Breslow JL (2006) n-3 Fatty acids and cardiovascular disease. Am J Clin Nutr 83(Suppl 6):1477S–1482S
Lemaitre RN, King IB, Mozaffarian D, Kuller LH, Tracy RP, Siscovick DS (2003) n-3 Polyunsaturated fatty acids, fatal ischemic heart disease, and nonfatal myocardial infarction in older adults: the cardiovascular health study. Am J Clin Nutr 77(2):319–325
Sankaran D, Bankovic-Calic N, Ogborn MR, Crow G, Aukema HM (2007) Selective COX-2 inhibition markedly slows disease progression and attenuates altered prostanoid production in Han:SPRD-cy rats with inherited kidney disease. Am J Physiol Renal Physiol 293(3):F821–F830
Brown JH, Bihoreau MT, Hoffmann S, Kranzlin B, Tychinskaya I, Obermuller N, Podlich D, Boehn SN, Kaisaki PJ, Megel N, Danoy P, Copley RR, Broxholme J, Witzgall R, Lathrop M, Gretz N, Gauguier D (2005) Missense mutation in sterile alpha motif of novel protein SamCystin is associated with polycystic kidney disease in (cy/+) rat. J Am Soc Nephrol 16(12):3517–3526
Reeves PG, Nielsen FH, Fahey GC Jr (1993) AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123(11):1939–1951
Peng CY, Sankaran D, Ogborn MR, Aukema HM (2009) Dietary soy protein selectively reduces renal prostanoids and cyclooxygenases in polycystic kidney disease. Exp Biol Med 234(7):737–743
Wojciechowski P, Juric D, Louis XL, Thandapilly SJ, Yu L, Taylor C, Netticadan T (2010) Resveratrol arrests and regresses the development of pressure overload- but not volume overload-induced cardiac hypertrophy in rats. J Nutr 140(5):962–968
Juric D, Yao X, Thandapilly S, Louis X, Cantor E, Chaze B, Wojciechowski P, Vasanji Z, Yang T, Wigle J, Netticadan T (2010) Defects in ryanodine receptor function are associated with systolic dysfunction in rats subjected to volume overload. Exp Physiol 95(8):869–879
Teixeira SR, Tappenden KA, Carson L, Jones R, Prabhudesai M, Marshall WP, Erdman JW (2004) Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr 134(8):1874–1880
Ogborn MR, Nitschmann E, Bankovic-Calic N, Weiler HA, Aukema HM (2010) Dietary soy protein benefit in experimental kidney disease is preserved after isoflavone depletion of diet. Exp Biol Med 235(11):1315–1320
Palanisamy N, Viswanathan P, Ravichandran MK, Anuradha CV (2010) Renoprotective and blood pressure-lowering effect of dietary soy protein via protein kinase C βII inhibition in a rat model of metabolic syndrome. Can J Physiol Pharmacol 88(1):28–37
Hagen MK, Lehenbauer-Ludke AR, Paludo AC, Schenkel P, Goncalves L, Fernandes TG, Caron R, Llesuy S, Mill JG, Bello-Klein A (2009) Diet with isolated soy protein reduces oxidative stress and preserves ventricular function in rats with myocardial infarction. Nutr Metab Cardiovasc Dis 19(2):91–97
Stichtenoth DO, Wagner B, Frolich JC (1998) Effect of selective inhibition of the inducible cyclooxygenase on renin release in healthy volunteers. J Investig Med 46(6):290–296
Farzamirad V, Aluko RE (2008) Angiotensin-converting enzyme inhibition and free-radical scavenging properties of cationic peptides derived from soybean protein hydrolysates. Int J Food Sci Nutr 59(5):428–437
Jensen BL, Schmid C, Kurtz A (1996) Prostaglandins stimulate renin secretion and renin mRNA in mouse renal juxtaglomerular cells. Am J Physiol 271(3 Pt 2):F659–F669
De Leo F, Panarese S, Gallerani R, Ceci LR (2009) Angiotensin converting enzyme (ACE) inhibitory peptides: production and implementation of functional food. Curr Pharm Des 15(31):3622–3643
Aukema HM, Adolphe J, Mishra S, Jiang J, Cuozzo FP, Ogborn MR (2003) Alterations in renal cytosolic phospholipase A2 and cyclooxygenases in polycystic kidney disease. FASEB J 17(2):298–300
Elberg D, Turman MA, Pullen N, Elberg G (2012) Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells. Prostaglandins Other Lipid Mediat 98(1–2):11–16
Elberg G, Elberg D, Lewis TV, Guruswamy S, Chen L, Logan CJ, Chan MD, Turman MA (2007) EP2 receptor mediates PGE2-induced cystogenesis of human renal epithelial cells. Am J Physiol Renal Physiol 293(5):F1622–F1632
Caligiuri SP, Aukema HM, Ravandi A, Guzman R, Dibrov E, Pierce GN (2014) Flaxseed consumption reduces blood pressure in patients with hypertension by altering circulating oxylipins via an alpha-linolenic acid-induced inhibition of soluble epoxide hydrolase. Hypertension 64(1):53–59
Ridao N, Luno J, Garcia de Vinuesa S, Gomez F, Tejedor A, Valderrabano F (2001) Prevalence of hypertension in renal disease. Nephrol Dial Transplant 16(Suppl 1):70–73
Pachori AS, Numan MT, Ferrario CM, Diz DM, Raizada MK, Katovich MJ (2002) Blood pressure-independent attenuation of cardiac hypertrophy by AT(1)R-AS gene therapy. Hypertension 39(5):969–975
Xin W, Wei W, Li X (2012) Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart 98(22):1620–1625
Chen J, Petrov A, Yaniz-Galende E, Liang L, de Haas HJ, Narula J, Hajjar RJ (2013) The impact of pressure overload on coronary vascular changes following myocardial infarction in rats. Am J Physiol Heart Circ Physiol 304(5):H719–H728
Medeiros FJ, Mothe CG, Aguila MB, Mandarim-de-Lacerda CA (2005) Long-term intake of edible oils benefits blood pressure and myocardial structure in spontaneously hypertensive rat (SHR) and streptozotocin diabetic SHR. Prostaglandins Other Lipid Mediat 78(1–4):231–248
Sergeant S, McQuail JA, Riddle DR, Chilton FH, Ortmeier SB, Jessup JA, Groban L, Nicolle MM (2011) Dietary fish oil modestly attenuates the effect of age on diastolic function but has no effect on memory or brain inflammation in aged rats. J Gerontol A Biol Sci Med Sci 66(5):521–533
Jahangiri A, Leifert WR, Kind KL, McMurchie EJ (2006) Dietary fish oil alters cardiomyocyte Ca2+ dynamics and antioxidant status. Free Radic Biol Med 40(9):1592–1602
Lennon-Edwards S, Schellhardt TA, Kuczmarski JM (2015) Antioxidant defense is increased in aged hearts following omega-3 supplementation in the absence of changes in inflammation. Physiol Res 64(3):433–438
Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, Collart F, Finne P, Fogarty DG, Groothoff JW, Hoitsma A, Nogier MB, Postorino M, Ravani P, Zurriaga O, Jager KJ, Gansevoort RT, ERA-EDTA Registry, EuroCYST Consortium, WGIKD (2014) Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int 86(6):1244–1252
Acknowledgments
This work was supported by a grant from the Natural Sciences and Engineering Research Council of Canada (NSERC). Support to N.I. was provided by the NSERC Food Advancement through Science and Training (FAST) program, the University of Manitoba Graduate Fellowship (UMGF), and the Libyan-North American scholarship program. S.T. was supported by the Manitoba Health Research Studentship. The authors thank Joy Gauthier and Tanja Winter for providing technical assistance.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
All the authors declare no competing interests.
About this article
Cite this article
Ibrahim, N.H.M., Thandapilly, S.J., Jia, Y. et al. Soy Protein Alleviates Hypertension and Fish Oil Improves Diastolic Heart Function in the Han:SPRD-Cy Rat Model of Cystic Kidney Disease. Lipids 51, 635–642 (2016). https://doi.org/10.1007/s11745-015-4095-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11745-015-4095-8